METI, a producer of patient simulation technology, has placed its Human Patient Simulator (HPS) in more than 250 hospitals, medical and nursing schools, community colleges, and military bases. Its acquisition of North American distribution rights to the Mentice product line will allow METI to serve new and existing customers with dramatically broadened opportunities to pursue excellence in medical education.
"In the five years that we have been developing and marketing our Human Patient Simulator", stated Lou Oberndorf, METI president, "health care educators have become convinced that medical simulation is the ultimate teaching tool, in terms of both cost-effectiveness and patient safety. Now, we are actively exploring the addition of new products, through alliances and distribution agreements with the world's finest producers of simulation technology. Mentice, with its exciting advances in the area of surgical training systems, provides a strikingly logical fit with METI's stated mission, to change the face of medical education."
The Mentice Corporation, with offices in Gothenburg, San Diego, and Cincinnati, is a pioneer in surgical education based on modern simulation technology. It provides turnkey solutions including hardware, software, and technical support, from entry-level skills acquisition to high-fidelity procedural training. With its range of products in the endovascular, laparoscopy, and arthroscopy areas, Mentice has established a new benchmark for minimally invasive surgical simulation. Mentice has sold and installed more than 150 of its systems worldwide.
"The partnership with METI will allow Mentice to provide an even stronger presence in North America", stated Jonas Ohlsson, president of Mentice AB, parent company to Mentice Inc. "By combining our resources, we will increase our capacity to sell, support, and deliver in the United States marketplace. This means an even better overall value for the users of our products."
According to David Hananel, president of Mentice Inc., both companies are broadly recognised for having successfully transitioned from their start-up phases, and have established a stable worldwide network of medical simulator users. "As a whole, the installation base of the two companies is far larger than that of any other manufacturer of high-fidelity medical simulators", Mr. Hananel pointed out. "Together, we can provide our customers with the only full range of medical simulation technology available in the world."
The METI/Mentice agreement was formally announced in the United States by Mr. Oberndorf at METI's annual gathering of medical simulation professionals, the Human Patient Simulator Network Conference, in St. Petersburg, Florida. More news on the Human Patient Simulator developed by METI is available in the following VMW articles: